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Transfection of human macrophages by lipoplexes via the
combined use of transferrin and pH-sensitive peptides
Sérgio Simões,*†§ Vladimir Slepushkin,* Elizabeth Pretzer,* Paul Dazin,\ Rogério Gaspar,†§
Maria C. Pedroso de Lima,‡§ and Nejat Düzgüneş*
*Department of Microbiology, School of Dentistry, University of the Pacific, San Francisco;
†Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, ‡Department of Biochemistry,
and §Center for Neurosciences, University of Coimbra, Coimbra, Portugal; and \Howard Hughes
Medical Institute, University of California, San Francisco

Abstract: The crucial function of macrophages in
a variety of biological processes and pathologies
render these cells important targets for gene therapeutic interventions. Commonly used synthetic gene
delivery vectors have not been successful in transfecting these non-dividing cells. A combination
strategy involving cationic liposomes to condense
and carry DNA, transferrin to facilitate cellular
uptake, and the pH-sensitive peptide GALA to
promote endosome destabilization, resulted in significant expression of a luciferase gene. Transfection of macrophages was dependent on the degree
of differentiation of the cells. The quaternary
complexes of cationic liposomes, DNA, transferrin,
and GALA exhibited a net negative charge, which
may obviate a limitation of cationic synthetic vectors in vivo. The lack of cytotoxicity and the
expected lack of immunogenicity of these complexes may render them useful for gene delivery to
macrophages in vivo. J. Leukoc. Biol. 65: 270–
279; 1999.
Key Words: gene delivery · cationic liposome · GALA · granulocytemacrophage colony stimulating factor · luciferase

INTRODUCTION

transduce with retroviruses, and this has led to the use of
adenovirus for that purpose [10, 11]. However, the size limit of
DNA carried and the risk of immunogenicity are serious
limitations to the use of such viruses. Consequently, it is
essential to develop efficient non-viral gene delivery strategies.
Recently, the use of DNA/glycosylated polylysine complexes was described as a promising strategy for receptormediated gene delivery to these cells. The conception of
such systems was based on the fact that macrophages express several membrane lectins that mediate endocytosis
[12, 13].
We investigated whether promoting receptor-mediated endocytosis of cationic liposome-DNA complexes by associating
them with transferrin [14–16] would result in transfection of
human peripheral blood monocyte-derived macrophages. We
tested complexes composed of 1,2-dioleoyl-3-(trimethylammonium) propane (DOTAP):dioleoylphosphatidylethanolamine
(DOPE) liposomes and the plasmid pCMVLuc encoding luciferase, at different lipid/DNA charge ratios. We also examined
whether the association to the complexes of two different
synthetic, pH-sensitive, fusogenic peptides, GALA [17] and the
influenza virus hemagglutinin HA-2 amino-terminal peptide
[18], would result in an enhancement of transfection. The
rationale was that these peptides would facilitate the destabilization of phagosomes or endocytotic vesicles in which the
complexes are internalized by macrophages, thereby mediating
the release of DNA into the cytoplasm and preventing its
degradation at the lysosomal level. Association of both transferrin and fusogenic peptides with cationic liposomes was also
tested for different lipid/DNA charge ratios.
Morphological and functional heterogeneity is an intrinsic
characteristic of macrophages and explains the recognized

Gene therapy is emerging as a promising therapeutic strategy
for the treatment of genetic metabolic diseases, cancer, and
AIDS. Macrophages are effector cells that play a major role in
the defense of the organism against diseases. Their broad
activity that includes tissue maintenance, immune regulation,
and pathogen control makes them crucial targets for gene
therapy [1]. Through the expression of therapeutic transgenes,
attempts have been made to modulate the function and
dysfunction of macrophages for the treatment of genetic metabolic diseases, including Gaucher’s disease [2–5], to promote
adoptive cellular immunotherapy against neoplastic cells [6], to
repair damaged tissues [7], or to inhibit HIV replication in
these cells [8, 9].
Several strategies have been developed to transfer genes into
monocytes or macrophages, most of them using viral vectors.
Being non-proliferating cells, macrophages are difficult to
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versatility of these cells. Among others, granulocyte-macrophage colony-stimulating factor (GM-CSF) is a polyfunctional
regulator involved in the proliferation and differentiation of
stem cells into circulating monocytes and also in the maturation
and activation of the mature cells finally produced [19]. The
latter process involves a variety of functions, including phagocytic capacity, cytotoxicity, expression of transferrin receptors,
chemotactic responses, and the production of various molecules
associated with inflammatory processes [20]. These functions
have all been shown to be expressed maximally at specific
stages of differentiation as a result of transient expression
promoted by exogenous stimulation. In this study, human blood
monocytes were plated and allowed to mature into macrophages
in the presence or absence of GM-CSF. The goal was to evaluate
the effect of this cytokine on the transfection activity mediated
by cationic lipid-DNA complexes (lipoplexes [21]), with or
without transferrin and/or fusogenic peptides. With the same
purpose, transfection of macrophages allowed to mature for
different times was also studied.
The risk of potentially adverse interactions with the biological milieu is one of the main drawbacks associated with the use
of cationic liposomes for gene delivery. In fact, the inhibitory
effect of serum on transfection mediated by lipoplexes has been
reported for different cell types [22–24] and represents a
serious limitation for their use in vivo [24]. We therefore
evaluated the effect of serum on transfection by the ternary and
quaternary complexes. The interaction of cationic liposomes
with negatively charged biological macromolecules could be
potentially minimized by utilizing lipoplexes with a net negative charge. Thus, we assessed the net charge of the various
complexes by electrophoretic mobility measurements. Cationic
liposomes can be toxic to cells, depending on the lipid
concentration, duration of treatment, the cell type, and the
confluency of the culture [25, 26]. To evaluate the cytotoxicity
of the different complexes, cell viability was assessed after
transfection. Our results have been presented earlier in preliminary form [27].

MATERIALS AND METHODS
Liposome preparation
The cationic lipid 1,2-dioleoyl-3-(trimethylammonium) propane (DOTAP), and
the zwitterionic co-lipid dioleoylphosphatidylethanolamine (DOPE), were purchased from Avanti Polar Lipids (Alabaster, AL). Cationic liposomes composed
of DOTAP or DOTAP/DOPE (1:1 weight ratio) were prepared by first drying a
film of lipid under argon and then in a vacuum oven at room temperature and
hydrating the lipid film with 1 mL deionized water, at a final concentration of 5
mg/mL. The multilamellar vesicles obtained were then sonicated briefly under
argon, extruded 21 times through polycarbonate filters of 50-nm pore diameter
using a Liposofast device (Avestin, Toronto, Canada), diluted five times with
deionized water, and filter-sterilized utilizing Millex 0.22-µm pore-diameter
filters (Millipore, Keene, NH).

Cells
Monocytes were obtained from buffy coats by centrifugation on a FicollHypaque (Histopaque-1077; Sigma, St. Louis, MO) gradient and plastic
adherence. Mononuclear cells separated by centrifugation were counted and
plated in Dulbecco’s modified Eagle’s medium, high-glucose (DME-HG)
medium without serum at a density of 1.4 3 106 cells/mL/well in 48-well

plates. It was assumed that approximately 5–10% of the cells plated were
recovered as macrophages. The cells were allowed to adhere overnight, then
washed, and the medium was replaced with DME-HG supplemented with 20%
(v/v) heat-inactivated fetal bovine serum (FBS, Sigma), 10% (v/v) human AB
serum (Advanced Biotechnologies, Columbia, MD), penicillin (100 U/mL),
streptomycin (100 µg/mL), and L-glutamine (2 mM), as described previously
[28]. The cells were left undisturbed in this medium for 6–7 days for
differentiation to occur. In some experiments human GM-CSF (hGM-CSF;
Boehringer Mannheim Biochemicals, Indianapolis, IN) was added to the wells
(final concentration of 100 IU/well) at the second day of differentiation. In other
experiments, cells were cultured for 8 more days in medium containing 20%
FBS, antibiotics, and L-glutamine, but in the absence of hGM-CSF.

Preparation of the complexes
Iron-saturated, heat-inactivated human transferrin was obtained from Collaborative Biomedical Products (via Becton Dickinson, Bedford, MA). The GALA
peptide [17, 29] and the peptide named HA-2, derived from the amino-terminal
sequence of the influenza virus hemagglutinin subunit HA2 [18] were
synthesized and high-performance liquid chromatography (HPLC)-purified by
the UCSF Biomolecular Resource Center. GALA is a 30-amino acid, pHsensitive, amphipathic peptide with the sequence WEAALAEALAEALAEHLAEALAEALEALAA. The sequence of HA-2 is GLFEAIAGFIENGWEG MIDGGGC. Complexes were prepared by sequentially mixing 100 µL of a
solution of 100 mM NaCl, 20 mM N-2-hydroxyethylpiperazine-N’-2ethanesulfonic acid (HEPES; Sigma), pH 7.4, with or without 32-µg ironsaturated human transferrin, with 5 or 10 µL of the liposome suspension (1 mg
lipid/mL) and incubated at room temperature for 15 min. One hundred
microliters of buffer containing 1 µg of pCMVLuc (plasmid VR-1216, kindly
provided by Dr. P. L. Felgner; Vical, Inc., San Diego, CA) were then added and
gently mixed, and the mixture was further incubated for 15 min at room
temperature. Peptide complexes were prepared in a similar manner, except that
the 100 µL of HEPES buffer solution contained 0.6 µg of the peptides.
Quaternary complexes were prepared by sequentially mixing liposomes with
the transferrin solution, then adding 0.6 µg of GALA (from a stock solution) and
finally 100 µL of a DNA solution containing 1 µg of the plasmid. Each addition
was followed by a 15-min incubation at room temperature.

Transfection activity
Cells were rinsed twice with serum-free medium and then covered with 0.3 mL
of DME-HG before lipid-DNA complexes were added. Lipid-DNA complexes
were added gently to the cells in a volume of 0.2 mL/well. After an incubation of
4 h (in 5% CO2 at 37°C) the medium was replaced with DME-HG containing
20% FBS, and the cells were further incubated for 24 or 48 h. The cells were
then washed twice with phosphate-buffered saline (PBS) and 100 µL of lysis
buffer (Promega, Madison, WI) were added to each well. The level of gene
expression in the lysates was evaluated by measuring light production by
luciferase using a scintillation counter protocol (Promega). The protein content
of the lysates was measured by the DC Protein Assay reagent (Bio-Rad,
Hercules, CA) using bovine serum albumin (Sigma) as the standard. The data
were expressed as nanograms of luciferase (based on a standard curve for
luciferase activity) per milligram of total cell protein.

Transfection efficiency
Transfection efficiency was evaluated by scoring the percentage of cells
successfully transfected. For this purpose two different plasmids were used:
pCMV.SPORT-b-gal (Life Technologies, Inc., Gaithersburg, MD) encoding
b-galactosidase, and a modified pHooKy-2 plasmid (Invitrogen, San Diego,
CA) encoding the Green Fluorescent Protein (GFP [30]). The latter plasmid
(pHooKy-2-GFP) was generated by inserting the GFP gene from a pTR-UF/UF1/
UF2 AAV cassette into pHooKy-2, and was kindly provided by Dr. Nancy Lee
and Dr. John Rossi (City of Hope, Duarte, CA). Briefly, cells transfected with 1
µg of pCMV.SPORT-b-gal were washed with PBS, fixed in a solution of 2%
formaldehyde and 0.2% glutaraldehyde, and stained with an X-gal containing
solution (Invitrogen). The cells were incubated at 37°C for 24 h and then
examined under a phase-contrast microscope for the development of blue color.
In the GFP assay, cells were transfected with 1 µg of pHooKy-2-GFP, washed
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with PBS, and detached from plastic by adding 0.5 mL of cell dissociation
buffer (Life Technologies, Inc.). They were then mixed with 0.5 mL of DME-HG
medium containing 1% of FBS and 1 µg/mL propidium iodide (Sigma) to assess
cell viability by flow cytometry. Green fluorescence was detected with a Becton
Dickinson single argon laser FACScan flow cytometer. GFP and propidium
iodide were excited at 488 nm and respective emissions were collected using a
530-nm band-pass filter (30-nm band width) for GFP and a 630-nm band-pass
filter (22-nm band width) for propidium iodide. Five thousand events were
recorded for each sample. Forward scatter and propidium iodide fluorescence
signals were used to gate the cell subset of interest and to eliminate debris, dead
cells, and cell aggregates.

Zeta potential measurements
Zeta potential measurements of the different lipid-DNA complexes, and ternary
or quaternary complexes with transferrin and/or peptides, were performed using
a Coulter DELSA 440 instrument (Coulter Corp., Miami, FL). The zeta potential
(z) was calculated for each scattering angle (8.6°, 17.1°, 25.6°, and 34.2°). Data
represent the mean 6 standard deviation obtained for the different angles of
two measurements.

Cell viability assay
After transfection under the different experimental conditions, cell viability
was quantified by a modified Alamar Blue assay [26]. The assay measures the
redox capacity of cells due to the production of metabolites as a result of cell
growth, and allows determination of viability over the culture period without the
detachment of adherent cells. Briefly, 1 mL of 10% (v/v) Alamar Blue dye
(AccuMed International Companies, Westlake, OH) in complete DME medium
was added to each well 45 h after the initial transfection period (4 h). After
2.5–4 h of incubation at 37°C, 200 µL of the supernatant were collected from
each well and transferred to 96-well plates. The absorbance at 570 and 600 nm
was measured with a microplate reader (Molecular Devices, Menlo Park, CA).
Cell viability (as a percentage of control cells) was calculated according to the
formula (A570–A600) of treated cells 3 100/(A570–A600) of control cells.

RESULTS
Enhancement of transfection of human blood
monocyte-derived macrophages by a targeting
ligand and/or fusogenic peptides
In an attempt to develop viable alternatives to the use of viral
vectors in gene therapy, several approaches have been tested to
enhance transfection mediated by cationic liposomes. The use
of ternary complexes composed of cationic liposomes, DNA,
and transferrin or fusogenic peptide was previously described
as a promising approach for gene delivery of proliferating cells
[14–16]. The goal of this strategy was to promote receptormediated endocytosis of the complexes (by the presence of
transferrin) and to improve cytoplasmic release of DNA from
endosomes (by the inclusion of a fusogenic peptide activated by
the mildly acidic pH in this compartment).
Here we tested these approaches in human blood monocytederived macrophages. These are non-proliferating cells that are
well known as being difficult to transfect by non-viral vectors,
as also evidenced by our results. Figure 1 shows the levels of
luciferase expression obtained in the presence or absence of
transferrin and/or fusogenic peptides. Two different lipid/DNA
charge ratios were tested because previous data indicated that
transfection activity may vary depending on the net charge of
the complexes [15, 16]. Association of transferrin with the
lipid-DNA complexes resulted in a significant enhancement of
transfection. This effect was more prevalent for the 2:1 (1/2)
lipid/DNA charge ratio where an enhancement of about 20-fold
was observed, as compared to controls, i.e., complexes composed of only cationic lipid and DNA (lipoplexes). These results

Fig. 1. Effect of the association of transferrin and/or fusogenic peptides with cationic liposome-DNA complexes on transfection of human blood monocyte-derived
macrophages. DOTAP:DOPE liposomes were mixed with 32 µg of transferrin and/or 0.6 µg of fusogenic peptides (either GALA or HA-2 peptide) and then mixed with
1 µg of pCMVLuc plasmid. The amount of transferrin used reflects the optimum determined by the experiments of Cheng [14] on HeLa cells. Macrophages were
obtained by plating monocytes in DME-HG supplemented with 20% FBS and 10% human AB serum for 7 days. hGM-CSF was added to the wells (final concentration
of 100 IU/mL) at the 2nd day of differentiation. After rinsing the cells with serum-free DME-HG medium, complexes were added and the cells incubated for 4 h at
37°C. After removing the complexes cells were further incubated for 48 h in medium containing 20% of FBS. The level of gene expression was evaluated as described
in Materials and Methods. The data are expressed as nanograms of luciferase per milligram of total cell protein (mean 6 SD obtained from triplicate wells), and are
representative of two independent experiments. (a) Significantly different from the corresponding control (P , 0.01). (b) Significantly different from the
corresponding control (P , 0.001). (c) Significantly different from the corresponding control (P , 0.05).
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suggest that receptor-mediated endocytosis of the ligandbearing complexes contributes to the enhancement of the
transfection levels mediated by cationic liposomes.
The association of the pH-sensitive synthetic peptide GALA
with the 1:1 (1/2) charge ratio complexes resulted also in an
increase of the level of luciferase expression as compared to
controls. Previous studies had shown 0.6 µg of GALA to be
optimal in enhancing transfection when complexed with cationic liposomes and 1 µg DNA [16]. No significant effect was
observed for the 2:1 charge ratio. On the other hand, the
association of the same amount of the synthetic peptide derived
from the amino terminus of the HA-2 subunit of the influenza
virus hemagglutinin did not result in any increase in gene
expression for either charge ratio tested.
The highest levels of luciferase expression were observed
when both transferrin and GALA were simultaneously combined with the lipid-DNA complexes. This effect was especially
evident for the 2:1 (1/2) lipid/DNA charge ratio, where an
increase of almost 50-fold was achieved compared with controls. The combined association of transferrin and the HA-2derived peptide did not produce any significant effect compared with controls for the 1:1 (1/2) charge ratio, whereas for
the 2:1 charge ratio the levels of luciferase expression did not
surpass the values obtained with the transferrin-lipid-DNA
complexes.
As readily noted from the standard deviations indicated by
the bars shown in Figure 1, a large variability in the levels of
luciferase gene expression was observed independently of the
type of complex used for transfection. This variability of
transfection activity was evident not only among independent
experiments (i.e., using batches of macrophages obtained from
the blood of different donors), but also among different wells of
the same experiment (i.e., using cells obtained from the blood of
the same donor). However, as noted below, the variability was
largely diminished when the cells were allowed to differentiate
for a longer period of time.

Effect of hGM-CSF and differentiation time
on transfection activity
Myeloid hematopoietic growth factors, like hGM-CSF, are
involved in the process of proliferation of monocytes and their
maturation into macrophages in vivo and in vitro [31]. These
cytokines also play a major role in the activation of these cells
in response to external stimuli. Therefore, we evaluated the
effect of hGM-CSF on the transfection activity of macrophages
mediated by lipoplexes and the quaternary complexes of
cationic liposomes-DNA-transferrin-GALA. For this purpose
approximately 1.4 3 105 cells were allowed to mature in
individual wells of 48-well plates for 7 days in the presence or
absence of 100 IU/mL of hGM-CSF. The above complexes were
then added to cells in a volume of 1 mL/well and incubated for
4 h at 37°C. Transfection activity was evaluated 48 h later.
Observation of the macrophages by phase contrast microscopy after this period of incubation in the presence of the
cytokine and just before starting the transfection procedure,
revealed some morphological differences between treated and
non-treated cells. Macrophages cultured in the presence of

hGM-CSF were larger, more elongated, and enriched with
granules. These cells also showed a higher metabolic activity
(noted by the faster color change of the medium) as compared to
untreated wells.
Figure 2A illustrates the effect of hGM-CSF on transfection
of human blood monocyte-derived macrophages. Promotion of
maturation and activation of the cells due to the presence of the
cytokine resulted in a significant enhancement of gene transfer
and expression mediated by DOTAP:DOPE liposomes. Although this effect was observed under all the conditions studied
(including controls), quaternary complexes composed of cationic liposomes-DNA-transferrin-GALA represented the most
efficient combination. As referred to in the previous section, the
highest levels of transfection for this particular type of complex
were obtained for the 2:1 lipid/DNA (1/2) charge ratio.
Alerted by the importance of the stage of maturation of
macrophages in transfection activity, we investigated whether
the time of maturation would affect this activity. Although there
is some controversy regarding the capacity of monocytes to
survive and to mature into macrophages when they are cultured
in the absence of myeloid hematopoietic growth factors [31, 32],
it was possible, using the experimental conditions described in
Materials and Methods, to maintain human blood monocytederived macrophages in culture for different times in the
absence of any cytokine.
As shown in Figure 2A, 7-day-old macrophages kept in the
absence of hGM-CSF were not transfected by the lipoplexes,
and exhibited some transgene activity with the quaternary
complexes. Considerably more promising results were observed
when macrophages (obtained from monocytes isolated from the
blood of the same donor) were maintained for 15 days in
culture. Data presented in Figure 2B clearly show that transfection of cells in such conditions resulted in a significant
enhancement of the levels of luciferase expression. This
enhancement was observed for both the ternary complexes
(containing transferrin) and the quaternary complexes (containing both transferrin and GALA), the highest levels of transfection being observed for the latter case. It should be noted that,
under these conditions, the variability in the levels of luciferase
expression was reduced compared to the results obtained with
7-day-old macrophages, as also illustrated by the relatively low
standard deviations (compare with Fig. 1).
Curiously, no significant differences in the levels of transfection activity were observed when macrophages were cultured
for 15 days in the presence of hGM-CSF as compared to cells
maintained for only 7 days in the presence of the cytokine (data
not shown).

Percentage of cells expressing reporter genes
Cellular distribution of the pCMV.SPORT-b-gal expression was
examined 48 h after transfection. Cells were analyzed for
b-galactosidase activity by a cytochemical assay. Unfortunately, no conclusive data could be drawn from these experiments because an intense blue stain was detected on the
majority of cells under all the conditions tested, including cells
that were not transfected (data not shown). These results
suggest that the blue staining of the macrophages occurred due
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Fig. 2. Effect of the presence of hGM-CSF and of differentiation time on transfection of human blood monocyte-derived macrophages. Transferrin, or transferrin and
GALA peptide, were associated with lipid-DNA complexes at the indicated theoretical charge ratios and the resulting ternary/quaternary complexes added to
adherent cells cultured (A) for 7 days in the presence or absence of hGM-CSF (100 IU/mL) and (B) for 15 days in the absence of hGM-CSF. Experiments were
performed as described in the legend to Figure 1. The data are expressed as nanograms of luciferase per milligram of total cell protein (mean 6 SD obtained from
triplicate wells), and are representative of two independent experiments. (a) Significantly different from the parallel experiment in the absence of hGM-CSF (P ,
0.01). (b) Significantly different from the parallel experiment in the absence of hGM-CSF (P , 0.05).

to either an endogenous b-gal activity or to a nonspecific
hydrolysis of the X-gal substrate as also suggested by Ferkol et
al. [13].
To circumvent this problem, complexes containing 1 µg of
pHooKy-2-GFP plasmid were prepared, as described in Materials and Methods, and used for transfection of macrophages.
After 48 h of incubation at 37°C the cells were detached and
analyzed by flow cytometry for the expression of Green
Fluorescence Protein. Results presented in Figure 3 illustrate
the percentage of positive gated cells for fluorescent protein
when different complexes were used for transfection of macrophages differentiated for 15 days in the absence of hGM-CSF.
The number of cells that expressed the transgene was very low
for any of the conditions tested. Nevertheless, it was evident
that the quaternary complexes, cationic liposomes-DNAtransferrin-GALA, were much more effective than control
complexes (complexes lacking transferrin or fusogenic peptide)
in mediating gene transfer to macrophages (2% of cells gated as
opposed to essentially none, Fig. 3, A and B). Figure 3C shows
the flow cytometry histograms observed for each case. The
274
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enhancement of the number of cells transfected when quaternary complexes were used resulted in a shift of the observed
fluorescence intensity.

Evaluation of the net charge of the complexes
In a previous study, complexes prepared at different lipid/DNA
(1/2) charge ratios were characterized regarding their overall
charge [15, 16]. It was shown that the association of transferrin
or the fusogenic peptides with the lipid-DNA complexes results
in a decrease of the zeta potential for any of the charge ratios
tested. This effect was attributed to the presence of negatively
charged amino acids in these compounds. We examined the
effect of the simultaneous association of transferrin and GALA
peptide on the overall charge of the complexes by measuring
the zeta potential. As expected, the concomitant association of
transferrin and the GALA peptide resulted in a significant
reduction of the zeta potential of the lipid-DNA complexes
(Table 1). Consequently, complexes with both 1:1 and 2:1
lipid/DNA charge ratios presented a net negative charge.
http://www.jleukbio.org

Fig. 3. Expression of Green Fluorescent Protein in human blood monocyte-derived macrophages. Scoring of the percentage of cells transfected when transfection
was mediated by either DOTAP:DOPE/DNA complexes (control formulation; top left panel) or quaternary complexes composed of transferrin-lipid-GALA-DNA (top
right panel). Bottom panel illustrates the overlay of fluorescence histograms obtained for both cases (thin solid line, control complexes; thick dotted line, quaternary
complexes). Transfection of cells cultured for 15 days in the absence of hGM-CSF took place for 4 h and then cells were incubated for 48 h at 37°C. After washing
with PBS, cells were detached from plastic with 0.5 mL of dissociation buffer. After the addition of 0.5 mL DME-HG medium containing 1% FBS and 1 µg/mL
propidium iodide, cells were analyzed for fluorescence with the use of a flow cytometer.

Effect of serum on transfection activity
As mentioned above, association of transferrin or both transferrin and the GALA peptide with the lipid-DNA complexes
resulted in net negatively charged complexes. Such complexes
TABLE 1. Zeta Potential (mV) of Liposome-DNA Complexes
(Lipoplexes) at Various Charge Ratios (1/2) and the Effect of
Transferrin or Fusogenic Peptides
Zeta potential (mV)
Lipoplex composition

DOTAP:DOPE/DNA
DOTAP:DOPE/DNA 1 Transferrin
DOTAP:DOPE/DNA 1 GALA
DOTAP:DOPE/DNA 1 HA-2
DOTAP:DOPE/DNA 1
Transferrin 1 GALA

Charge ratio
1:1

(Lipid/DNA) (1/2)
2:1

2.4 6 5.1
238.6 6 5.2

42.8 6 0.5
25.0 6 2.2
235.3 6 3.6
211.0 6 3.5

would be expected not to interact as avidly with net negatively
charged macromolecules present in biological fluids as would
net positively charged lipoplexes. To test this hypothesis,
complexes were added to cells in the presence of cell culture
medium containing 20% FBS and incubated for 4 h at 37°C.
Figure 4 illustrates the levels of transfection observed when
control complexes, transferrin complexes, or transferrin 1
GALA peptide-associated complexes at different lipid/
DNA charge ratios were used under these conditions. The
presence of 20% serum during the transfection procedure
resulted in a reduction of the levels of luciferase gene
expression for the optimal tested condition, i.e. the combined association of transferrin and GALA with the lipidDNA complexes (compare with Fig. 1). However, the effect of
serum was not very significant in the case of transferrin
complexes.

237.8 6 4.0

Zeta potential measurements of the different DOTAP:DOPE/DNA complexes
were performed using a Coulter DELSA 440 instrument. The liposomes were
associated with either 32 µg of transferrin or 0.6 µg of GALA peptide, or both,
and then mixed with 1 µg DNA. Data represent the mean 6 SD obtained for four
different angles in two measurements.

Effect of the different complexes on cell viability
We examined the effect on cell viability of transfection with the
lipoplexes at two different charge ratios, as well as their
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Fig. 4. Effect of the presence of serum on luciferase gene expression in human blood monocyte-derived macrophages. Transferrin and/or GALA peptide were
associated with lipid-DNA complexes at the indicated theoretical charge ratios and the resulting complexes added to adherent cells cultured for 7 days in the
presence of hGM-CSF (100 IU/mL) and 20% of FBS, and the cells incubated for 4 h at 37°C. After removing the complexes cells were further incubated for 48 h in
medium containing 20% FBS. The level of gene expression was evaluated as described in Materials and Methods. Data are expressed as nanograms of luciferase per
milligram of total cell protein (mean 6 SD obtained from triplicate wells), and are representative of two independent experiments. (a) Significantly different from the
parallel experiment in the absence of serum (P , 0.05). (b) Significantly different from the parallel experiment in the absence of serum (P , 0.01).

complexes with transferrin or the combination of transferrin and
GALA, 45 h after the initial 4-h incubation of the cells with the
complexes (Fig. 5). No significant effect on cell viability was
observed. Cell metabolic activity was unaltered even for the
highest lipid/DNA charge ratio tested (2:1), where about 8 µg of
total lipid were used. The addition of transferrin, or both
transferrin and fusogenic peptides, also did not result in any
toxicity to the cells. These results were confirmed by both the

total cell protein quantification and morphological observations
of treated and untreated cells.

DISCUSSION
Transfection of macrophages represents a significant challenge
in gene therapy approaches that could utilize these cells. The

Fig. 5. Effect of DOTAP:DOPE DNA complexes, with or without transferrin or fusogenic peptides, on the viability of human blood monocyte-derived macrophages.
Cells in 48-well plates were exposed to lipid-DNA complexes with or without transferrin or the fusogenic peptides at different charge ratios for 4 h at 37°C, as
described in Materials and Methods. Cell viability was measured by the Alamar Blue assay 45 h after the 4-h transfection period, and was expressed as percent of the
control. Data represent the mean 6 SD obtained from duplicate wells.

276

Journal of Leukocyte Biology

Volume 65, February 1999

http://www.jleukbio.org

major role played by macrophages in antigen presentation, and
the control of cancer and viral infections make them crucial
targets for therapeutic gene delivery. However, macrophages
are non-proliferating cells that are very difficult to transfect by
non-viral methods, including cationic liposomes.
In this work we tested different strategies to mediate
transfection of macrophages by lipid-based complexes. Because differentiated and mature macrophages express transferrin receptors [32], and because ternary complexes composed of
cationic liposomes, DNA, and transferrin are highly effective in
transfecting proliferating cells [15, 16], we evaluated how the
promotion of receptor-mediated endocytosis of lipoplexes via
transferrin would affect transfection of macrophages. Although
such a ligand would not mediate selective targeting to macrophages in vivo, association of transferrin with DOTAP:DOPE/
DNA complexes most likely facilitates the internalization of the
complexes, thus resulting in an enhancement of the levels of
luciferase expression (Fig. 1). In this study we have not
attempted to demonstrate whether transferrin lipoplexes are
indeed internalized through the transferrin receptor, and if so,
how the DNA penetrates the endosome membrane to enter the
cytoplasm and reach the nucleus. Such studies are currently
underway in our laboratory.
Because macrophages are professional phagocytes [33], it is
important to avoid, or at least to decrease, the degradation of the
internalized genetic material by lysosomes. For this purpose,
low pH-activated membrane-active peptides [17, 18, 34] were
also associated with the lipid-DNA complexes. The rationale
was to induce the destabilization of endosomes or phagosomes
and thereby mediate the entry of the DNA or the complexes into
the cytoplasm before fusion with lysosomes. In our studies the
synthetic GALA peptide was more effective than the influenza
HA-2 peptide (Fig. 1). GALA undergoes a transition from a
random coil at pH 7.5 to an amphipathic a-helix at pH 5.0,
under which conditions it strongly interacts with phospholipid
membranes to induce fusion, contents leakage, and phospholipid flip-flop [17, 29, 34, 35]. The covalent attachment of
GALA to polyamidoamine dendrimers was found previously to
enhance transfection of cell lines by 1:1 (terminal amine:
phosphate) complexes by several orders of magnitude [36].
Nevertheless, it was through the combination of both strategies
(i.e., promotion of internalization and facilitation of endosome
destabilization) that the highest levels of transfection were
obtained in our experiments. These results suggest that the
association of fusogenic peptides with lipoplexes may be a
promising method to facilitate the intracellular protection of
DNA. This method may have advantages over other strategies,
including the addition of lysosomotropic agents like chloroquine [12, 18], or the association of inactivated adenovirus [37],
that may result in cytotoxicity or an immune response, respectively.
Efficient gene transfer to human blood monocyte-derived
macrophages was significantly dependent on their stage of
differentiation and maturation promoted by hGM-CSF. As
indicated earlier, morphological and functional properties of
macrophages are strongly related to the different degree of
maturation of these cells. Therefore, an increase of the expression of membrane transferrin receptors may be one of the

reasons why an enhancement of gene transfer was achieved
under these conditions. Maturation heterogeneity of the cells
may explain the variability observed in the levels of luciferase
expression among wells. This variability may also be caused by
the relatively low levels of transfection activity observed.
The importance of the stage of differentiation in the transfection of macrophages was also demonstrated when cells were
allowed to differentiate for longer periods (15 instead of 7 days)
in the absence of any cytokine (Fig. 2B). Under these conditions, a significant enhancement of the levels of luciferase
expression was observed, as well as a decrease in the variability
among cells, as compared to those obtained under other
conditions (compare with Fig. 2A). Once again, a reasonable
explanation for these results might be the increase in the
number of transferrin receptors, resulting in a higher extent of
internalization of the complexes. Another concurrent possibility is that, as a consequence of the higher and more uniform
stage of maturation, more favorable conditions were found for
the endosome-disrupting action of the peptide. This is suggested by the larger differences in the levels of transfection
observed between ternary and quaternary complexes (absence
or presence of GALA, respectively) as compared with results
obtained in parallel experiments carried out with 7-day-old
macrophages treated with hGM-CSF. In accordance with previous reports [12], we noted that luciferase gene expression was
transient, a very low luciferase activity being observed 72 h
after transfection (data not shown). This may be a reflection of
the lack of integration of the plasmid into chromosomal DNA,
as expected from non-viral vectors.
The ability of the different complexes to promote gene
transfer was also evaluated by scoring the percentage of cells
expressing Green Fluorescence Protein, defined as the transfection efficiency. The use of quaternary complexes resulted in an
increase in the number of cells successfully transfected compared with controls, i.e. plain lipoplexes. It should be noted that
the results described regarding the GFP assay were obtained
under the experimental conditions that led to the highest levels
of transfection activity, i.e., using macrophages differentiated
for 15 days in the absence of hGM-CSF. Studies of transfection
efficiency performed with 7-day-old macrophages, in the
absence or presence of the cytokine, led to even lower numbers
of cells successfully transfected. Although this information
seems to suggest that there is a relationship between the
number of cells transfected (transfection efficiency) and the
overall levels of gene expression (transfection activity) obtained
for the different experimental conditions, the low levels of gene
expression usually observed hamper the establishment of an
accurate (faithful) correlation between these two parameters.
Although the low percentage of cells scored as expressing this
plasmid (2%) was below our expectations, it should be noted
that even lower levels of transfection efficiency have been
described by Ferkol et al. [13] whose studies involved the use of
mannosylated polylysine conjugates for the delivery of luciferase and b-galactosidase plasmids to macrophages, both in vitro
and in vivo. The use of a modified version of the plasmid
promoting not only higher expression but also brighter Green
Fluorescence Protein (EGFP [38]) may enhance the sensitivity
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of the assay and hence result in the detection of a larger
percentage of transfected cells.
The preparation of the quaternary complexes involved the
addition of transferrin and GALA to the liposomes followed by
addition of DNA. For the different complexes tested, the 2:1
lipid/DNA charge ratio was the condition leading to the highest
levels of luciferase expression. Because part of the positive
charge of the lipid was involved in the interaction with the
transferrin and the GALA peptide, both of which are net
negatively charged compounds, an excess of cationic lipid
seems to be required for an efficient interaction with the added
DNA. Although the lipoplex itself at this lipid/DNA charge
ratio is positively charged, zeta potential measurements revealed that the overall charge of the quaternary complexes was
negative (Table 1). Curiously, this particular type of complex
did not produce enhanced transfection of proliferating cells
over that obtained with ternary complexes containing transferrin (unpublished data). On the other hand, quaternary complexes prepared with a 4:1 lipid/DNA charge ratio, exhibiting a
positive zeta potential, did not show any enhancement of
transfection of macrophages as compared to the 2:1 complexes
(data not shown). These results suggest that the use of net
negatively charged complexes may contribute to an enhancement of specificity of the targeting ligand because strong
electrostatic interactions will not dominate the binding of the
complex to the net negatively charged cell membrane. Previous
results [15, 16] also suggested that an excess of positive charge
may mask the ligand, thus decreasing the efficiency of the
receptor-mediated process.
The presence of both transferrin and the GALA peptide led
to the formation of net negatively charged complexes. Complexes with such characteristics are likely to alleviate some of
the problems associated with the in vivo use of highly positively
charged complexes, including the inability to efficiently transfect cells beyond the vascular endothelial cells and the avid
complexation with serum or extracellular matrix proteins. The
lower extent of interaction with the macromolecules in biological fluids may reinforce the target specificity and also avoid
activation of the complement system, with consequent enhancement of the stability and circulation times of the complexes
[39, 40].
Although it was expected that negatively charged complexes
would not interact significantly with serum components, in our
experiments the presence of 20% serum partially inhibited the
transfection activity of the quaternary complexes. However, still
higher levels of transfection were observed as compared to
controls under the same conditions. The inhibitory effect of
serum was essentially negligible when only transferrin was
combined with the complexes. A possible explanation for these
observations is the extraction of GALA from the complexes by
serum components. Further studies are required to address this
issue. It is interesting to note that when the ternary complexes
(i.e., cationic liposomes-DNA-transferrin) were used for transfection of proliferating cells in previous studies, the presence of
10% FBS did not significantly inhibit transgene delivery and
expression [15, 16].
The results presented here show clearly that the combined
association of cationic liposomes with a targeting ligand and a
278
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fusogenic peptide is a valuable strategy to promote efficient in
vitro gene transfer into macrophages. The quaternary complexes described are easy to prepare, and consequently to
scale-up, are targeted to a cell surface receptor, provide
sufficient protection of DNA (outside and inside the cells), and
are non-cytotoxic. Furthermore, these complexes exhibit physicochemical features that may be highly advantageous for their
use in intravenous gene delivery. Therefore, these systems
represent the prototype of promising alternatives to the use of
viral vectors for gene therapy based on the expression of
therapeutic genes in macrophages.
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